The US Food and Drug Administration (FDA) has issued new guidelines recommending the intramuscular injection of generic drug promethazine hydrochloride, reducing the risk of severe chemical irritation and tissue damage. The medicine is used to manage allergic reactions, motion sickness and post-operative nausea and vomiting.
Looking At the Year Ahead: What Can We Expect Within the Cybersecurity Landscape?
In 2024, healthcare organisations experienced significant disruptions due to numerous data breaches and ransomware attacks. This impacted daily operations and caused financial hardship for some.
